中文

English

首頁

最新消息

關於我們

商品介紹

技術支援

培訓課程

合作委託

聯絡我們

原廠連結

Facebook

2020-07-24

Webinar: From B cells to yeast—diverse approaches to rapid discovery of COVID-19 therapeutic antibodies

Date: Thursday, August 6, 2020 at 8:00 PDT | 11:00 EDT | 16:00 BST | 17:00 CEST

Presented by Select Science
The novel coronavirus SARS-CoV-2 pandemic has brought about an urgency to rapidly develop monoclonal antibodies (mAbs) that neutralize and inhibit this virus. These are the most readily manufacturable therapeutics that can be administered to prevent or treat COVID-19. To meet this global challenge, scientists are now pursuing diverse approaches that integrate the use of either patient B cells, yeast or phage display with cell sorting, sequencing and advanced bioinformatics to advance therapeutic mAb discovery.

Join our free educational webinar to learn about the approaches used by two scientific groups who have accelerated antibody discovery with these pipeline technologies.

Learning objectives

Who should attend

This webinar will provide insights to researchers who want to learn how integrated approaches can be implemented to support swift therapeutic mAb discovery and validation.


Register Now!


上一頁
Top